2021-11-16-世界卫生组织-Cervical_cancer_Guinea_2021_country_profile_1页_64kb

Cervical Cancer Profile in Guinea

Morbidity and Mortality

• Crude incidence: 30.5 cases per 100,000 women (2020).
• Age-standardized incidence: 50.1 cases per 100,000 women (2020).
• Cumulative risk: 5.5% developing cervical cancer by age 74 (2020).
• Deaths: Cervical cancer accounting for 1,500 deaths (2019); mortality-to-incidence ratio is 0.71 (2020).
• Population and deaths: Total female population: 6,605,000 (2019); total female deaths: 55,100 (2019).

Primary Prevention

• HPV vaccination: Not included in the national vaccination schedule; coverage is 39% among girls for the first dose. (2020).
• Risk factors: Tobacco use prevalence: 2.0% among women aged 15+ years (2020); other factors where data unavailable.

Secondary Prevention

• Screening: No national cervical cancer screening program exists (2021); VIA (Visual Inspection with acetic acid) is used by some, with 13% of women ever screened and 10% screened in the last 5 years.

Treatment and Supportive Care

• Guidelines: National guidelines exist for cervical cancer management (2021).
• Resources: Limited availability of radiotherapy and brachytherapy units, with 0 units per 10,000 patients reported.
• Personnel: General medical staff: unspecified per 10,000 patients; specialized roles like radiation oncologists, pathologists, and surgeons not reported or limited.

WHO Elimination Strategy

• Guinea aims to align with WHO targets for 2030 but lacks data on specific progress.